BWM
WST icon

Biltmore Wealth Management’s West Pharmaceutical WST Stock Holding History

Biltmore Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$633K Sell
1,707
-103
-6% -$36.4K 0.2% 39
2026
Q2 		$650K Buy
+1,810
New +$553K 0.2% 39

Other funds holding WST

BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return
BRCM
Bright Rock Capital Management Hanover, Massachusetts $529M AUM 8.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return
RFA
RTD Financial Advisors Philadelphia, Pennsylvania $914M AUM 11.18% 1-Year Est. Return
KPWG
KFA Private Wealth Group Tysons, Virginia $425M AUM 14.36% 1-Year Est. Return

Biltmore Wealth Management's WST Position: Q3 2026 in Review

Biltmore Wealth Management reduced its West Pharmaceutical (WST) stake by 5.7% in Q3 2026, selling an estimated $36.4K and leaving 1,707 shares worth $633K. The position accounts for 0.2% of the portfolio, ranked #39.

Biltmore Wealth Management first reported a position in WST in Q2 2026 and has held it in 2 quarters since. The position peaked at $650K in Q2 2026. 29 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Biltmore Wealth Management held 1,707 shares of West Pharmaceutical worth $633K as of Q3 2026.
  • Biltmore Wealth Management sold 103 West Pharmaceutical shares in Q3 2026, an estimated $36.4K.
  • West Pharmaceutical made up 0.2% of Biltmore Wealth Management's portfolio in Q3 2026, its #39 holding.
  • Biltmore Wealth Management first reported a position in West Pharmaceutical in Q2 2026 and has held it in 2 quarters since.
  • Biltmore Wealth Management's West Pharmaceutical position peaked at $650K in Q2 2026.
  • 29 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Biltmore Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.